US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation

 
• By Grace Moser

CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach. 

stick figure person kicking down a door. two other closed doors follow.
FDA CDER Director wants to create "connective tissue" to prevent the organization from operating in silos. • Source: Shutterstock

More from US FDA

More from Agency Leadership